Cargando…

Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience

Antibody-mediated rejection (AMR) is not uncommon after renal transplantation and is harder to handle compared to cell-mediated rejection. When refractory to conventional therapies, rituximab is an attractive option. This study aims to examine the effectiveness of rituximab in refractory late acute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surendra, M., Raju, S. B., Raju, N., Chandragiri, S., Mukku, K. K., Uppin, M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015507/ https://www.ncbi.nlm.nih.gov/pubmed/27795623 http://dx.doi.org/10.4103/0971-4065.177207

Ejemplares similares

Idiopathic nodular glomerulosclerosis: Report of two cases and review of literature
por: Chandragiri, S., et al.
Publicado: (2016)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

Expanding the antibody-mediated component of plasma cell-rich acute rejection: A case series
por: Uppin, M. S., et al.
Publicado: (2016)

Successful catheter reinsertion in a case of Paecilomyces varioti peritonitis in a patient on continuous ambulatory peritoneal dialysis
por: Mandarapu, S. B., et al.
Publicado: (2015)

Goodpasture's disease in a patient with Kartagener's syndrome: An unusual association
por: Mandarapu, S. B., et al.
Publicado: (2016)

Coronary Angiography Profile at the Time of Hemodialysis Initiation in End-Stage Renal Disease Population: A Retrospective Analysis
por: Surendra, M., et al.
Publicado: (2018)

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017)

Acute Ciprofloxacin-Induced Crystal Nephropathy with Granulomatous Interstitial Nephritis
por: Goli, R., et al.
Publicado: (2017)

A Clinicopathological Study of 267 Patients with Diabetic Kidney Disease Based on the Renal Pathology Society – 2010 Classification System
por: Chandragiri, Susmitha, et al.
Publicado: (2020)

Clinical Profile and Outcome of Posterior Reversible Encephalopathy Syndrome in Hemodialysis Patients
por: Chandragiri, S., et al.
Publicado: (2018)

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
por: Piñeiro, Gastón J, et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection
por: Hychko, G., et al.
Publicado: (2011)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

Modest Improvements in Refractory Antibody-Mediated Rejection After Prolonged Treatment
por: Degner, Kenna R., et al.
Publicado: (2021)

Unusual cause of glomerular deposition disease: Collagenofibrotic glomerulopathy
por: Nimmagadda, S., et al.
Publicado: (2017)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Late Cardiac Antibody-Mediated Rejection: A Only Heart Duel
por: Costa, Catarina, et al.
Publicado: (2022)

Comparative Analysis of Determinants and Outcome of Early and Late Acute Antibody Mediated Rejection (ABMR)
por: Karthikeyan, Balasubramanian, et al.
Publicado: (2023)

The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients
por: An, Gun Hee, et al.
Publicado: (2014)

AZD-1222/immune-globulin/rituximab: Coronary antibody-mediated rejection, thrombosis and lack of efficacy: case report
Publicado: (2022)

Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
por: Jade, Jui Dilip, et al.
Publicado: (2017)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Hemispherotomy for late post-traumatic super-refractory status epilepticus in an adult
por: Nayak, Raghavendra, et al.
Publicado: (2017)

Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies
por: Zhu, Lan, et al.
Publicado: (2023)

Granulomatous interstitial nephritis: Our experience of 14 patients
por: Naidu, G. D., et al.
Publicado: (2013)

Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results
por: Mella, Alberto, et al.
Publicado: (2018)

Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
por: Joachim, Emily, et al.
Publicado: (2020)

Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival
por: Sun, Qiquan, et al.
Publicado: (2013)

Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection
por: Einecke, Gunilla, et al.
Publicado: (2018)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
por: Nourié, Nicole, et al.
Publicado: (2022)

Rituximab in refractory sarcoidosis: a single centre experience
por: Cinetto, Francesco, et al.
Publicado: (2015)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients
por: Nanmoku, Koji, et al.
Publicado: (2019)

SD-OCT based management of traumatic sub-macular hemorrhage-Our experience
por: Sampangi, Raju, et al.
Publicado: (2013)

Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
por: Keske, Aysenur, et al.
Publicado: (2022)

Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
por: de Weerd, Annelies, et al.
Publicado: (2014)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_skgqc48vv0kooh750c292vruho